Kalaris Therapeutics, Inc. (KLRS) — DEF 14A Filings
All DEF 14A filings from Kalaris Therapeutics, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Kalaris Sets Virtual Annual Meeting, Board Elections on Tap
— Jul 1, 2025 Risk: low
Kalaris Therapeutics, Inc. (KLRS) filed a Definitive Proxy Statement (DEF 14A) on July 1, 2025, for its Annual Meeting of Stockholders scheduled for August 12, -
Allovir Files 2025 Proxy Statement
— Dec 6, 2024 Risk: medium
Allovir, Inc. filed its Definitive Proxy Statement (DEF 14A) on December 6, 2024, for its 2025 annual meeting of stockholders, scheduled for January 9, 2025. Th -
AlloVir, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 23, 2024 Risk: low
Allovir, Inc. (KLRS) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. AlloVir, Inc. will hold its 2024 Annual Meeting of Stockholders online on
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX